Caption Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.83M Sell
892,600
-7,400
-0.8% -$56.6K 0.04% 437
2025
Q4
$8.75M Buy
900,000
+47,800
+6% +$406K 0.06% 368
2025
Q3
$3.57M Buy
852,200
+59,800
+8% +$382K 0.03% 613
2025
Q2
$7.36M Buy
792,400
+767,400
+3,070% +$6.7M 0.08% 291
2025
Q1
$244K Buy
+25,000
New +$309K ﹤0.01% 1240
2023
Q4
Sell
-659,900
Closed -$11.3M 1612
2023
Q3
$11.3M Buy
+659,900
New +$13M 0.17% 139

Other funds holding REPL

Caption Management's REPL Position: Q1 2026 in Review

Caption Management increased its Replimune Group (REPL) stake by 98% in Q1 2026, buying an estimated $1.71M and bringing the position to 451,822 shares worth $3.46M. The position accounts for 0.02% of the portfolio, ranked #646.

Caption Management first reported a position in REPL in Q2 2023 and has held it in 5 quarters since. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Caption Management held 451,822 shares of Replimune Group worth $3.46M as of Q1 2026.
  • Caption Management bought 223,252 Replimune Group shares in Q1 2026, an estimated $1.71M.
  • Replimune Group made up 0.02% of Caption Management's portfolio in Q1 2026, its #646 holding.
  • Caption Management first reported a position in Replimune Group in Q2 2023 and has held it in 5 quarters since.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.